Clinical Trial Update: Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease [Phase 2]

View source ↗

Summary

The completed Phase 2 trial investigates how the cholinergic system contributes to gait dysfunction in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Virginia | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED